Press Release: Precede Biosciences Presents Data at AACR 2025 Demonstrating Ability to Resolve Gene Expression for Thousands of Tumor-Specific Genes from a Simple Blood Test
BOSTON, April 27, 2025 (GLOBE NEWSWIRE) -- Precede Biosciences, a company impacting the development and use of precision medicines with a first-in-class comprehensive epigenomic liquid biopsy platform, today shared the company’s scientific presentation from the 2025 American Association for Cancer Research (AACR) Annual Meeting taking place from April 25 to 30, 2025, in Chicago, Illinois.
Press Release: Precede Biosciences Presents Data at AACR 2025 Demonstrating Ability to Resolve Gene Expression for Thousands of Tumor-Specific Genes from a Simple Blood Test - Newscast
Mon, 31 Mar 2025 05:00:00 GMT SAN DIEGO, CA / ACCESS Newswire / March 31, 2025 / Ensysce Biosciences ... Act and such applicable state securities laws. This press release shall not constitute an offer to sell or a solicitation ...
